AL-LAD: Difference between revisions

From TripSit wiki
Jump to navigation Jump to search
No edit summary
No edit summary
 
(13 intermediate revisions by 5 users not shown)
Line 1: Line 1:
[[File:allad.jpg|right|200px]]
[[File:allad.jpg|left|200px]]


'''AL-LAD''' is a hallucinogenic drug, lysergamide and an analogue of [[LSD]]. It is described by Alexander Shulgin in the book ''TiHKAL'' (Tryptamines i Have Known And Loved). AL-LAD is reported as having some subtle experiential differences to LSD (such as increased visuals), and also appears to be slightly shorter lasting. AL-LAD doses are similar to those of LSD, depending on purity.


AL-LAD, also known as 6-allyl-6-nor-lysergic acid diethylamide, is a hallucinogenic drug, lysergamide and an analogue of LSD. It is described by Alexander Shulgin in the book TiHKAL (Tryptamines i Have Known And Loved). AL-LAD is reported as having some subtle experiential differences to LSD (such as the visuals), and also appears to be slightly shorter lasting and slightly more potent.
== History ==


=History=
AL-LAD was originally discovered in the 90s by David Nichols along with several LSD analogues, and later reviewed by Alexander Shulgin. The drug was popularised for recreational use in 2013, as part of the progression through the release of chemicals Shulgin discusses and provides syntheses for in his book TiHKAL. It became increasingly popular among recreational users, via the conduit of its legality and easy access through the Internet. Since then, a few countries such as the UK have moved to illegalise the chemical.


AL-LAD was originally developed by David Nichols along with several LSD analogues, and later reviewed by Alexander Shulgin. The drug was popularised for recreational use in 2012, as part of the progression through the release of chemicals Shulgin discusses and provides syntheses for in his books TiHKAL and PiHKAL. It became increasingly popular among recreational users, via the conduit of its legality and easy access through the Internet. Since then, a few countries such as the UK have moved to illegalise the chemical.
== Dosage ==


= Dosage =
{| class="wikitable"
|+ Oral
| Common || 60-160μg
|-
| Strong || 300μg+
|}


Common: 60-160 μg
== Duration ==


Strong: 300 μg
{| class="wikitable"
|+ Oral
| Onset|| 45-90 minutes
|-
| Duration|| 4-6 hours
|}


= Duration =
== Effects ==
 
Onset: 45-90 minutes
 
Duration: 6-8 hours
 
= Effects =


In large, AL-LAD is reported as having a very similar effect profile to [[LSD]]. However, many subjective differences are noted - a different 'headspace' and slightly different visuals are noted, along with what may be perceived as a slightly 'happier' push.  
In large, AL-LAD is reported as having a very similar effect profile to [[LSD]]. However, many subjective differences are noted - a different 'headspace' and slightly different visuals are noted, along with what may be perceived as a slightly 'happier' push.  


= Harm Reduction =
== Harm Reduction ==


Similar to other psychedelics, and particularly LSD, AL-LAD is relatively safe for recreational use. There are many prevalent [[Common_Misconceptions_About_Psychedelics|misconceptions around psychedelic use]] which can be safely ignored, but care should still be taken to use the drug responsibly.
While widespread use of AL-LAD is relatively new and therefore its full impact is unknown, it is likely that it has a similar safety profile to [[LSD]]. Refer to [[LSD]] and [[Psychedelics#Harm_Reduction|Psychedelic Harm Reduction]] for more information.


== General ==
== Chemistry and Pharmacology ==
Systemaic name:6-allyl-6-nor-lysergic acid diethylamide


Avoid driving and operating heavy machinery.
=== Reactivity ===
AL-LAD does not cause a colour change with the marquis, mecke or mandelin reagents but does cause the ehrlich's reagent to turn purple because of the presence of the indole moiety in its structure.


== Tolerance ==
== Legal status ==


Wait at least four to fourteen days for full effect due to rapid tolerance build, though it's generally advised to wait longer between trips. Ingesting AL-LAD no more than once a month is advised due to the adverse psychological effects of chronic use. The [[addiction]] potential of AL-LAD is likely nonexistant, save rare cases in which a person becomes psychologically addicted.
=== America ===
 
== Mental Illness ==
 
Psychedelics are known to potentially cause latent mental illness to manifest. Those with mental illnesses should not ingest AL-LAD. Those with a family history of mental illness, including but not limited to depression, schizophrenia, and bipolar should use AL-LAD with extreme caution. AL-LAD may cause dangerous physiological and psychological reactions when used in conjunction with lithium or tricyclic antidepressants.
 
= Legal status =
 
== America ==


Controlled in the United States via the Federal Analog Act, but only if it is intended for human consumption.
Controlled in the United States via the Federal Analog Act, but only if it is intended for human consumption.


== United Kingdom ==
=== United Kingdom ===


AL-LAD was scheduled as a Class A drug in the UK in June 2014, despite not carrying out any of the usual recommended research on proving any harm is associated with recreational use of the drug.
AL-LAD was scheduled as a Class A drug in the UK in June 2014, despite not carrying out any of the usual recommended research on proving any harm is associated with recreational use of the drug.


=Links=
== Links ==
* [https://www.erowid.org/library/books_online/tihkal/tihkal01.shtml The TiHKAL entry for AL-LAD]
* [https://www.erowid.org/library/books_online/tihkal/tihkal01.shtml The TiHKAL entry for AL-LAD]
* [https://en.wikipedia.org/wiki/AL-LAD Wikipedia]
* [http://tripsit.me/the-story-of-al-lad The Story of AL-LAD]


[[Category:Drugs]]
[[Category:Drugs]]
[[Category:Psychedelic]]
[[Category:Psychedelic]]
[[Category:Research Chemical]]

Latest revision as of 07:04, 21 February 2016

AL-LAD is a hallucinogenic drug, lysergamide and an analogue of LSD. It is described by Alexander Shulgin in the book TiHKAL (Tryptamines i Have Known And Loved). AL-LAD is reported as having some subtle experiential differences to LSD (such as increased visuals), and also appears to be slightly shorter lasting. AL-LAD doses are similar to those of LSD, depending on purity.

History

AL-LAD was originally discovered in the 90s by David Nichols along with several LSD analogues, and later reviewed by Alexander Shulgin. The drug was popularised for recreational use in 2013, as part of the progression through the release of chemicals Shulgin discusses and provides syntheses for in his book TiHKAL. It became increasingly popular among recreational users, via the conduit of its legality and easy access through the Internet. Since then, a few countries such as the UK have moved to illegalise the chemical.

Dosage

Oral
Common 60-160μg
Strong 300μg+

Duration

Oral
Onset 45-90 minutes
Duration 4-6 hours

Effects

In large, AL-LAD is reported as having a very similar effect profile to LSD. However, many subjective differences are noted - a different 'headspace' and slightly different visuals are noted, along with what may be perceived as a slightly 'happier' push.

Harm Reduction

While widespread use of AL-LAD is relatively new and therefore its full impact is unknown, it is likely that it has a similar safety profile to LSD. Refer to LSD and Psychedelic Harm Reduction for more information.

Chemistry and Pharmacology

Systemaic name:6-allyl-6-nor-lysergic acid diethylamide

Reactivity

AL-LAD does not cause a colour change with the marquis, mecke or mandelin reagents but does cause the ehrlich's reagent to turn purple because of the presence of the indole moiety in its structure.

Legal status

America

Controlled in the United States via the Federal Analog Act, but only if it is intended for human consumption.

United Kingdom

AL-LAD was scheduled as a Class A drug in the UK in June 2014, despite not carrying out any of the usual recommended research on proving any harm is associated with recreational use of the drug.

Links